IRIS Accounts Production v24.2.0.383 SC718831 director 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC7188312023-03-31SC7188312024-03-31SC7188312023-04-012024-03-31SC7188312022-01-03SC7188312022-01-042023-03-31SC7188312023-03-31SC718831ns15:Scotland2023-04-012024-03-31SC718831ns14:PoundSterling2023-04-012024-03-31SC718831ns10:Director12023-04-012024-03-31SC718831ns10:PrivateLimitedCompanyLtd2023-04-012024-03-31SC718831ns10:SmallEntities2023-04-012024-03-31SC718831ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-31SC718831ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-31SC718831ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-31SC718831ns10:FullAccounts2023-04-012024-03-31SC718831ns10:RegisteredOffice2023-04-012024-03-31SC718831ns5:CurrentFinancialInstruments2024-03-31SC718831ns5:CurrentFinancialInstruments2023-03-31SC718831ns5:Non-currentFinancialInstruments2024-03-31SC718831ns5:Non-currentFinancialInstruments2023-03-31SC718831ns5:ShareCapital2024-03-31SC718831ns5:ShareCapital2023-03-31SC718831ns5:RetainedEarningsAccumulatedLosses2024-03-31SC718831ns5:RetainedEarningsAccumulatedLosses2023-03-31SC718831ns5:PlantMachinery2023-03-31SC718831ns5:PlantMachinery2023-04-012024-03-31SC718831ns5:PlantMachinery2024-03-31SC718831ns5:PlantMachinery2023-03-31SC718831ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-31SC718831ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: SC718831 (Scotland)
















Unaudited Financial Statements for the Year Ended 31 March 2024

for

Alieva Biotec Limited

Alieva Biotec Limited (Registered number: SC718831)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Alieva Biotec Limited

Company Information
for the Year Ended 31 March 2024







DIRECTOR: C McKay





REGISTERED OFFICE: C/O Mclay, Mcalister & Mcgibbon LLP
145 St Vincent Street
Glasgow
G2 5JF





REGISTERED NUMBER: SC718831 (Scotland)





ACCOUNTANTS: McLay McAlister & McGibbon LLP
Chartered Accountants
145 St Vincent Street
Glasgow
G2 5JF

Alieva Biotec Limited (Registered number: SC718831)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 41,687 21,579

CURRENT ASSETS
Debtors 5 37,650 19,853
Cash at bank 70,668 4,584
108,318 24,437
CREDITORS
Amounts falling due within one year 6 (52,895 ) (25,346 )
NET CURRENT ASSETS/(LIABILITIES) 55,423 (909 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

97,110

20,670

CREDITORS
Amounts falling due after more than one
year

7

(12,133

)

(16,857

)

PROVISIONS FOR LIABILITIES (7,921 ) (442 )
NET ASSETS 77,056 3,371

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 77,055 3,370
77,056 3,371

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Alieva Biotec Limited (Registered number: SC718831)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 September 2024 and were signed by:





C McKay - Director


Alieva Biotec Limited (Registered number: SC718831)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Alieva Biotec Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
The company’s policy is to review the remaining useful lives and residual value of all tangible fixed assets on an on-going basis and to adjust the depreciation charge to reflect the remaining useful economic life and residual value.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

Alieva Biotec Limited (Registered number: SC718831)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 24,083
Additions 22,763
At 31 March 2024 46,846
DEPRECIATION
At 1 April 2023 2,504
Charge for year 2,655
At 31 March 2024 5,159
NET BOOK VALUE
At 31 March 2024 41,687
At 31 March 2023 21,579

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Other debtors 37,650 19,853

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Bank loans and overdrafts 5,437 5,437
Taxation and social security 17,747 3,751
Other creditors 29,711 16,158
52,895 25,346

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.24 31.3.23
£    £   
Bank loans 12,133 16,857

8. SECURED DEBTS

The following secured debts are included within creditors:

31.3.24 31.3.23
£    £   
Factored debt 25,662 7,659

The factored debt is secured by a floating charge over the assets of the company.